Seroprevalence of TORCH Viral Agents in Pregnant Women in Turkey: Systematic Review and Meta-Analysis
Enregistré dans:
| Publié dans: | Pathogens vol. 14, no. 1 (2025), p. 37 |
|---|---|
| Auteur principal: | |
| Autres auteurs: | , , |
| Publié: |
MDPI AG
|
| Sujets: | |
| Accès en ligne: | Citation/Abstract Full Text + Graphics Full Text - PDF |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|
MARC
| LEADER | 00000nab a2200000uu 4500 | ||
|---|---|---|---|
| 001 | 3159541694 | ||
| 003 | UK-CbPIL | ||
| 022 | |a 2076-0817 | ||
| 024 | 7 | |a 10.3390/pathogens14010037 |2 doi | |
| 035 | |a 3159541694 | ||
| 045 | 2 | |b d20250101 |b d20251231 | |
| 084 | |a 231547 |2 nlm | ||
| 100 | 1 | |a Elmas Pinar Kahraman Kilbas |u Department of Medical Laboratory Techniques, Health Services Vocational School, Fenerbahce University, 34758 Istanbul, Turkey; <email>elmspnrkk@gmail.com</email> | |
| 245 | 1 | |a Seroprevalence of TORCH Viral Agents in Pregnant Women in Turkey: Systematic Review and Meta-Analysis | |
| 260 | |b MDPI AG |c 2025 | ||
| 513 | |a Journal Article | ||
| 520 | 3 | |a Rubella Virus, Cytomegalovirus (CMV), Herpes Simplex Virus-2 (HSV-2), Hepatitis B (HBV) and Hepatitis C virus (HCV) can cause serious fetal disease. The seropositivity rates of these agents vary among countries and geographic regions. This study aimed to analyze the prevalence rates and diagnostic methods used in studies investigating the seroprevalence of viral pathogens in the TORCH group among pregnant women in Turkey between 2005 and 2024. A systematic search was conducted using electronic databases between January 2005 and January 2024. A total of 60 studies meeting the inclusion criteria were included. Data quality control was assessed using the Joanna Briggs Institute guideline prevalence studies checklist. Heterogeneity was measured using the I-squared (I2) statistic in the Comprehensive Meta Analysis (CMA) program. The average seropositivity rates for Rubella, CMV, HSV-2, HBV and HCV in Turkey were determined as 91.18%, 94.81%, 35.52%, 1.66% and 0.25%, respectively. When the diagnostic methods were examined, it was determined that ELISA and ECLIA methods were used most frequently. The seropositivity of the agents did not show statistically significant differences according to the year periods, geographical regions and age of the patients (p > 0.05). The highest prevalence rates of Rubella and HSV-2 in pregnant women were reported in the Mediterranean region, the highest prevalence rates of CMV and HCV in the Southeastern Anatolia region and the highest seroprevalence of Anti HBs in the Marmara region. The results of this study support the necessity of increasing public awareness in the control of fetal infection caused by TORCH viral agents, prenatal screening, vaccination for Rubella and HBV and compliance with hygiene conditions for agents such as CMV, HSV-2 and HCV. The results of this study highlight the need to increase public awareness on prenatal screening for the control of fetal infection caused by all TORCH viral agents, vaccination for Rubella and HBV and compliance with hygiene conditions for agents such as CMV, HSV-2 and HCV. | |
| 651 | 4 | |a Turkey | |
| 651 | 4 | |a United States--US | |
| 653 | |a Hepatitis B | ||
| 653 | |a Zika virus | ||
| 653 | |a Hepatitis C | ||
| 653 | |a Hygiene | ||
| 653 | |a Asymptomatic | ||
| 653 | |a Rubella | ||
| 653 | |a Herpes simplex | ||
| 653 | |a Public awareness | ||
| 653 | |a Miscarriage | ||
| 653 | |a Data analysis | ||
| 653 | |a Heterogeneity | ||
| 653 | |a Quality control | ||
| 653 | |a Hepatitis | ||
| 653 | |a Statistical methods | ||
| 653 | |a Meta-analysis | ||
| 653 | |a Vaccination | ||
| 653 | |a Infections | ||
| 653 | |a Software | ||
| 653 | |a Pathogens | ||
| 653 | |a Womens health | ||
| 653 | |a Pregnancy | ||
| 653 | |a Congenital diseases | ||
| 653 | |a Serology | ||
| 653 | |a Industrialized nations | ||
| 653 | |a Statistical analysis | ||
| 653 | |a Chronology | ||
| 653 | |a Fetuses | ||
| 653 | |a Human immunodeficiency virus--HIV | ||
| 653 | |a Publications | ||
| 653 | |a Cytomegalovirus | ||
| 653 | |a Diagnostic systems | ||
| 653 | |a Viral infections | ||
| 653 | |a Babies | ||
| 700 | 1 | |a Ciftci, Ihsan Hakki |u Department of Medical Microbiology, Faculty of Medicine, Sakarya University, 54100 Sakarya, Turkey; <email>handetoptan@sakarya.edu.tr</email> | |
| 700 | 1 | |a Kilbas, Imdat |u Medical Microbiology Doctorate Program, Institute of Health Sciences, Istanbul University, 34093 Istanbul, Turkey; <email>imdtklbs@gmail.com</email> | |
| 700 | 1 | |a Toptan, Hande |u Department of Medical Microbiology, Faculty of Medicine, Sakarya University, 54100 Sakarya, Turkey; <email>handetoptan@sakarya.edu.tr</email> | |
| 773 | 0 | |t Pathogens |g vol. 14, no. 1 (2025), p. 37 | |
| 786 | 0 | |d ProQuest |t Biological Science Database | |
| 856 | 4 | 1 | |3 Citation/Abstract |u https://www.proquest.com/docview/3159541694/abstract/embedded/L8HZQI7Z43R0LA5T?source=fedsrch |
| 856 | 4 | 0 | |3 Full Text + Graphics |u https://www.proquest.com/docview/3159541694/fulltextwithgraphics/embedded/L8HZQI7Z43R0LA5T?source=fedsrch |
| 856 | 4 | 0 | |3 Full Text - PDF |u https://www.proquest.com/docview/3159541694/fulltextPDF/embedded/L8HZQI7Z43R0LA5T?source=fedsrch |